Scientific Working Groups
To fulfill its research mission with specificity, the Center for Stem Cell Biology & Regenerative Medicine has established a set of scientific Working Groups for focused research and clinical interactions. All four Working Groups are focused on enhancing the quality and quantity of applications to relevant funding sources. The Center for Stem Cell Biology & Regenerative Medicine’s Steering Committee will conduct primary review of new applications to initiate Working Groups as the need arises. The Center for Stem Cell Biology & Regenerative Medicine Director will consult with the appropriate Department Chair before appointing a faculty member to head a working group. The four existing groups include:
- Cardiovascular Stem Cell Working Group: Novel activities of stem cells will be exploited to develop effective, safe, and durable therapies for heart disease. Vascular stem cell research is currently included in this Working Group.
- Hematopoietic and Cancer Stem Cell Working Group: This Working Group studies biology and applications of hematopoietic stem cells and also seeks to learn how to better kill cancer stem cells, using novel drugs and immunotherapies. Hematopoietic stem cell transplantation (aka bone marrow transplantation) research is included in this Working Group.
- Mesenchymal Stem Cell Working Group: This Working Group is currently focused on the ability of Mesenchymal stem cells to form cartilage and bone. This group also includes research on skin stem cells.
- Neural Stem Cell Working Group: This Working Group studying neural stem cells brings expertise in developmental biology and has developed new three-dimensional models of brain with implications for neurologic degenerative diseases. Research on neural injury and repair is included in this Working Group. This group also includes research on stem cell reprograming.
The immediate goal of each Working Group is to develop individual and multi-laboratory research projects and to apply for funding. Faculty collaboration in these areas will also provide a natural infrastructure for relevant education and implementation of clinical trials.
To catalyze clinical regenerative medicine research and care, the Center for Stem Cell Biology & Regenerative Medicine must interact closely with the relevant clinical divisions (hematopoietic stem cell [aka bone marrow] transplantation, organ transplantation, and other emerging stem cell therapies).